Ładuje się......
Armed Replicating Adenoviruses for Cancer Virotherapy
Conditionally replicating adenoviruses (CRAds) have many advantages as agents for cancer virotherapy and have been safely employed in human clinical trials. However, replicating adenoviruses have been limited in their ability to eliminate tumors by oncolysis. Thus, the efficacy of these agents must...
Zapisane w:
Główni autorzy: | , |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
2009
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2683179/ https://ncbi.nlm.nih.gov/pubmed/19197323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2009.3 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|